Sharing a good local news story for patients - early days for the adoption of gene therapies for IRD and to emphasis how new/cutting edge PYC ocular therapies are.
I get the feeling helping patients is what motivates Sue and the PYC team - and are striving hard towards.
The complexity/delivery of current tech is worth noting, PYC will surprise ease of an intravenous injection within a GP type consulting room vs full fledged operating theatre will surprise the industry I think
https://www.insightnews.com.au/sydney-surgeon-details-first-luxturna-gene-therapy-allowing-patient-to-see-stars/#mobile-site-navigation
